ETF午评：创新药ETF国泰领涨4.70%，黄金股ETF基金领跌2.27%
news flash·2025-06-09 03:33
Group 1 - The ETF market showed mixed performance at midday, with the innovative drug ETFs leading gains [1] - Guotai Innovative Drug ETF (517110) rose by 4.70%, while Hong Kong Innovative Drug ETF (520700) increased by 4.65% [1] - Gold stock ETFs experienced declines, with Gold Stock ETF Fund (159315) down by 2.27% and Gold Stock ETF (159322) falling by 2.04% [1] Group 2 - The ability to buy Hong Kong stocks through A-share accounts without the need for Hong Kong Stock Connect is highlighted [1]